Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM‐HF trial

Diuretic Treatment in Heart Failure

(2017) David H. Ellison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure

(2016) Michael R. Zile et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF

(2015) Adam D. DeVore et al.   EUROPEAN JOURNAL OF HEART FAILURE

Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction

(2015) Kevin Damman et al.   EUROPEAN JOURNAL OF HEART FAILURE

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combined Neprilysin and Renin-Angiotensin System Inhibition for the Treatment of Heart Failure

(2014) Orly Vardeny et al.   JACC-Heart Failure

Interaction Between Loop Diuretic-Associated Mortality and Blood Urea Nitrogen Concentration in Chronic Heart Failure

(2011) Jeffrey M. Testani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)

(2010) Serge Masson et al.   JOURNAL OF CARDIAC FAILURE

Cardiorenal Syndrome in Acute Decompensated Heart Failure

(2009) M. Sarraf et al.   Clinical Journal of the American Society of Nephrology

The Sympathetic Nervous System in Heart Failure

(2009) Filippos Triposkiadis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY